AAM
RDY icon

Augustine Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Augustine Asset Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$213K Sell
14,710
-235,540
-94% -$3.18M 0.04% 114
2026
Q1 		$3.47M Buy
250,250
+1,041
+0.4% +$14.5K 0.78% 25
2025
Q4 		$3.5M Sell
249,209
-544
-0.2% -$7.63K 0.7% 23
2025
Q3 		$3.49M Sell
249,753
-1,449
-0.6% -$20.9K 0.7% 22
2025
Q2 		$3.78M Buy
251,202
+2,046
+0.8% +$29.2K 1.01% 19
2025
Q1 		$3.29M Sell
249,156
-588
-0.2% -$8.11K 0.96% 23
2024
Q4 		$3.94M Sell
249,744
-3,756
-1% -$56.4K 1.04% 18
2024
Q3 		$4.03M Buy
253,500
+380
+0.2% +$6.12K 1.41% 17
2024
Q2 		$3.86M Buy
253,120
+905
+0.4% +$13K 1.49% 16
2024
Q1 		$3.7M Sell
252,215
-880
-0.3% -$12.8K 1.54% 18
2023
Q4 		$3.52M Buy
253,095
+8,650
+4% +$116K 1.56% 19
2023
Q3 		$3.27M Sell
244,445
-8,225
-3% -$111K 1.51% 18
2023
Q2 		$3.19M Sell
252,670
-1,585
-0.6% -$18.5K 1.47% 18
2023
Q1 		$2.89M Sell
254,255
-1,510
-0.6% -$16.3K 1.43% 20
2022
Q4 		$2.65M Buy
255,765
+137,340
+116% +$1.48M 1.46% 20
2022
Q3 		$1.24M Buy
+118,425
New +$1.26M 0.82% 30
2022
Q2 		– Sell
-19,225
Closed -$214K – 95
2022
Q1 		$214K Sell
19,225
-2,025
-10% -$23K 0.11% 87
2021
Q4 		$278K Hold
21,250
– – 0.14% 80
2021
Q3 		$277K Sell
21,250
-2,110
-9% -$28.1K 0.15% 76
2021
Q2 		$343K Sell
23,360
-1,365
-6% -$19.1K 0.18% 64
2021
Q1 		$304K Hold
24,725
– – 0.16% 67
2020
Q4 		$353K Hold
24,725
– – 0.18% 58
2020
Q3 		$344K Sell
24,725
-1,035
-4% -$12.3K 0.2% 62
2020
Q2 		$273K Hold
25,760
– – 0.16% 62
2020
Q1 		$208K Buy
25,760
+440
+2% +$3.67K 0.15% 67
2019
Q4 		$205K Buy
+25,320
New +$200K 0.12% 69

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Augustine Asset Management's RDY Position: Q2 2026 in Review

Augustine Asset Management reduced its Dr. Reddy's Laboratories (RDY) stake by 94% in Q2 2026, selling an estimated $3.18M and leaving 14,710 shares worth $213K. The position accounts for 0.04% of the portfolio, ranked #114.

Augustine Asset Management first reported a position in RDY in Q4 2019 and has held it in 26 quarters since. The position peaked at $4.03M in Q3 2024. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Augustine Asset Management held 14,710 shares of Dr. Reddy's Laboratories worth $213K as of Q2 2026.
  • Augustine Asset Management sold 235,540 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $3.18M.
  • Dr. Reddy's Laboratories made up 0.04% of Augustine Asset Management's portfolio in Q2 2026, its #114 holding.
  • Augustine Asset Management first reported a position in Dr. Reddy's Laboratories in Q4 2019 and has held it in 26 quarters since.
  • Augustine Asset Management's Dr. Reddy's Laboratories position peaked at $4.03M in Q3 2024.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Augustine Asset Management's 13F filing for Q2 2026, filed 13 Jul 2026.